ImmunityBio (IBRX) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.62
-0.44
-0.25
-0.07

Details

Expected EPS
-0.07046
Actual EPS
-0.62
Surprise EPS
-0.55
Surprise Percent
+779.93%

Description

ImmunityBio (IBRX) has reported earnings of -0.62 per share for Q2 2026.

0 Comments

Share your thoughts